Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Friday, December 1, at 1:00 p.m. ET / 10:00 a.m. PT

After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

Featured Speakers: 

• Irena Melnikova, Ph.D., partner, Pfizer Ventures
• Rakhshita Dhar, sr. director, venture investments, Leaps by Bayer
• Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)